MetaADEDB 2.0 @ LMMD
Oxaliplatin
(ZROHGHOFXNOHSO-BNTLRKBRSA-N)
Structure
SMILES
OC(=O)C(=O)O.N[C@@H]1CCCC[C@H]1N.[Pt+2]
Type(s)
Approved; Investigational
ATC code(s)
L01XA03
Molecular Formula:
C8H16N2O4Pt++
Molecular Weight:
399.302
Log P:
0.7687
Hydrogen Bond Acceptor:
6
Hydrogen Bond Donor:
4
TPSA:
126.64
CAS Number(s):
61825-94-3
Synonym(s)
1.
Oxaliplatin
2.
1,2-Diaminocyclohexane Platinum Oxalate
3.
1,2-Diamminocyclohexane(trans-1)oxolatoplatinum(II)
4.
ACT 078
5.
ACT-078
6.
Cis-oxalato-(trans-l)-1,2-diaminocyclohexane-platinum(II)
7.
Eloxatin
8.
Eloxatine
9.
L-OHP Cpd
10.
Oxalato-(1,2-cyclohexanediamine)platinum II
11.
Oxaliplatin, (SP-4-2-(1R-trans))-isomer
12.
Oxaliplatin, (SP-4-2-(1S-trans))-isomer
13.
Oxaliplatin, (SP-4-3-(cis))-isomer
14.
Oxaliplatine
15.
Platinum(II)-1,2-cyclohexanediamine Oxalate
16.
1,2 Diaminocyclohexane Platinum Oxalate
17.
ACT078
External Link(s)
MeSHD000077150
PubChem Compound6857599
25199921
ChEBI31941
DrugBankDB00526
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1HypotensionFAERS: 7US FAERS
2ErythemaFAERS: 4US FAERS
3MalaiseFAERS: 4US FAERS
4PruritusFAERS: 4US FAERS
5ChillsFAERS: 3US FAERS
6LaryngospasmFAERS: 3US FAERS
7Respiratory FailureFAERS: 3US FAERS
8TachycardiaFAERS: 3US FAERS
9VomitingFAERS: 3US FAERS
10DysphoniaFAERS: 2US FAERS
11NauseaFAERS: 2US FAERS
12PallorFAERS: 2US FAERS
13ThrombocytopeniaFAERS: 2US FAERS
14Abdominal PainFAERS: 1US FAERS
15AstheniaFAERS: 1US FAERS
16BronchospasmFAERS: 1US FAERS
17Chest PainFAERS: 1US FAERS
18ClonusFAERS: 1US FAERS
19CyanosisFAERS: 1US FAERS
20DizzinessFAERS: 1US FAERS
21Drug specific antibodyFAERS: 1US FAERS
22DyspepsiaFAERS: 1US FAERS
23FormicationFAERS: 1US FAERS
24General physical health deteriorationFAERS: 1US FAERS
25HeadacheFAERS: 1US FAERS
26HypersensitivityFAERS: 1US FAERS
27Hypertensive crisisFAERS: 1US FAERS
28Laryngeal ObstructionFAERS: 1US FAERS
29Laryngeal discomfortFAERS: 1US FAERS
30Livedo ReticularisFAERS: 1US FAERS
31NeutropeniaFAERS: 1US FAERS
32OverdoseFAERS: 1US FAERS
33Peptic UlcerFAERS: 1US FAERS
34Pharmaceutical product complaintFAERS: 1US FAERS
35Rash erythematousFAERS: 1US FAERS
36RetchingFAERS: 1US FAERS
37StridorFAERS: 1US FAERS
38SyncopeFAERS: 1US FAERS
39WheezingFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.